Literature DB >> 19662927

Dexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphine.

Chad M Brummett1, Kavita A Trivedi, Anna V Dubovoy, Daniel W Berland.   

Abstract

Buprenorphine is a partial agonist/antagonist used for the outpatient management of pain and addiction. It avidly binds to the opioid receptors and has a long and varied half-life. Its effects can impair the efficacy of opioids used for postoperative pain. The authors present a case of a patient managed with buprenorphine as an outpatient who presented for revision spine surgery and had significant postoperative pain that was successfully treated with hydromorphone and dexmedetomidine. This is the first reported use of dexmedetomidine for postoperative pain in a patient treated with buprenorphine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19662927     DOI: 10.5055/jom.2009.0018

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  8 in total

Review 1.  To Stop or Not, That Is the Question: Acute Pain Management for the Patient on Chronic Buprenorphine.

Authors:  T Anthony Anderson; Aurora N A Quaye; E Nalan Ward; Timothy E Wilens; Paul E Hilliard; Chad M Brummett
Journal:  Anesthesiology       Date:  2017-06       Impact factor: 7.892

2.  Use of dexmedetomidine for pain control.

Authors:  Irina Grosu; Patricia Lavand'homme
Journal:  F1000 Med Rep       Date:  2010-12-17

3.  Case Series of Successful Postoperative Pain Management in Buprenorphine Maintenance Therapy Patients.

Authors:  Barbara L Leighton; Lara W Crock
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

4.  Dexmedetomidine attenuates neuropathic pain in chronic constriction injury by suppressing NR2B, NF-κB, and iNOS activation.

Authors:  Feng Liang; Miao Liu; Xin Fu; Xueying Zhou; Peng Chen; Fanglei Han
Journal:  Saudi Pharm J       Date:  2017-04-28       Impact factor: 4.330

5.  Perioperative Pain and Addiction Interdisciplinary Network (PAIN): protocol of a practice advisory for the perioperative management of buprenorphine using a modified Delphi process.

Authors:  Saam Azargive; Joel S Weissman; Akash Goel; Harsha Shanthanna; Karim S Ladha; Wiplove Lamba; Scott Duggan; John G Hanlon; Tania Di Renna; Philip Peng; Hance Clarke
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

Review 6.  Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review

Authors:  Yasmin Sritapan; Sean Clifford; Alexander Bautista
Journal:  Balkan Med J       Date:  2020-05-14       Impact factor: 2.021

7.  The perioperative patient on buprenorphine: a systematic review of perioperative management strategies and patient outcomes.

Authors:  Akash Goel; Saam Azargive; Wiplove Lamba; Joel Bordman; Marina Englesakis; Sanjho Srikandarajah; Karim Ladha; Tania Di Renna; Harsha Shanthanna; Scott Duggan; Philip Peng; John Hanlon; Hance Clarke
Journal:  Can J Anaesth       Date:  2018-11-27       Impact factor: 5.063

8.  Molecular mechanisms underlying the analgesic property of intrathecal dexmedetomidine and its neurotoxicity evaluation: an in vivo and in vitro experimental study.

Authors:  Hongxing Zhang; Fang Zhou; Chen Li; Min Kong; He Liu; Peng Zhang; Song Zhang; Junli Cao; Licai Zhang; Hong Ma
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.